Related Pages for APOLLOHOSP
- Option Chain
- Straddle OC
- Max Pain
- Put Call Ratio
- Option Analytics
- Call OI vs Put OI
- Strike Flow
- Call OI Chg vs Put OI Chg
- Call Vol vs Put Vol
- Buildup & Unwinding
- Vega Divergence
- Multi Strike OI
- Price vs OI
- Time Series
- Volatility Skew
- Premium Decay
- Future Chain
- Future Intraday Analysis
- Technical
- Financials
- Chart
- About
No results found.
APOLLOHOSP
8108.5
Related News - APOLLOHOSP
Apollo Hospitals Enterprise: Guidance - Management expects the Apollo HealthTech demerger and listing to be completed by Q4 FY27, with the company reaching an annualized revenue of INR 25,000 crores by that quarter. - Concall Update
22 May 2026 08:44 AM
Apollo Hospitals Enterprise: Guidance - Management expects the Apollo HealthTech demerger and listing to be completed by Q4 FY27, with the company reaching an annualized revenue of INR 25,000 crores by that quarter. - Concall Update
Apollo Hospitals Enterprise: Guidance - For new hospitals, management is sticking to an assumption of INR 140-150 crores in losses for the full year, with the peak quarterly loss potentially occurring in Q2. - Concall Update
22 May 2026 08:44 AM
Apollo Hospitals Enterprise: Guidance - For new hospitals, management is sticking to an assumption of INR 140-150 crores in losses for the full year, with the peak quarterly loss potentially occurring in Q2. - Concall Update
Apollo Hospitals Enterprise: Guidance - Apollo 24/7 is on track to achieve breakeven in Q1 FY27, excluding ESOP costs, and breakeven including ESOP costs by Q3 FY27. || Apollo HealthCo is guiding for an exit EBITDA margin of 6.5% to 7% by Q4 FY27, driven by private label growth and reduced digital losses. - Concall Update
22 May 2026 08:44 AM
Apollo Hospitals Enterprise: Guidance - Apollo 24/7 is on track to achieve breakeven in Q1 FY27, excluding ESOP costs, and breakeven including ESOP costs by Q3 FY27. || Apollo HealthCo is guiding for an exit EBITDA margin of 6.5% to 7% by Q4 FY27, driven by private label growth and reduced digital losses. - Concall Update
Apollo Hospitals Enterprise: Guidance - The Healthcare Services business is expected to see mid-teen growth in FY27, with established units improving margins by at least 100 basis points. - Concall Update
22 May 2026 08:44 AM
Apollo Hospitals Enterprise: Guidance - The Healthcare Services business is expected to see mid-teen growth in FY27, with established units improving margins by at least 100 basis points. - Concall Update
Apollo Hospitals: Confirms Demerger of Apollo HealthCo Progressing After Shareholder Meeting on June 24, 2026, Aiming for Q4 FY27 Listing and ₹25,000 Cr Annual Revenue Target. - Concall Update
21 May 2026 04:02 PM
Apollo Hospitals: Confirms Demerger of Apollo HealthCo Progressing After Shareholder Meeting on June 24, 2026, Aiming for Q4 FY27 Listing and ₹25,000 Cr Annual Revenue Target. - Concall Update
Apollo Hospitals; Merges Cradle Business With Cloudnine At A 35X EBITDA Multiple, Showcasing Strong Asset Value; Retains 9.9% Stake And Board Seat To Enhance Focus On Mother-Child Care And Diagnostics. - Concall Update
21 May 2026 03:46 PM
Apollo Hospitals; Merges Cradle Business With Cloudnine At A 35X EBITDA Multiple, Showcasing Strong Asset Value; Retains 9.9% Stake And Board Seat To Enhance Focus On Mother-Child Care And Diagnostics. - Concall Update
Apollo Hospitals: Management Claims Apollo 24/7 Is Set To Reach Cash Breakeven In Q1 FY27, With Reduced Digital Losses Expected To Increase HealthCo Margin To 6.5–7% By Year-End. - Concall Update
21 May 2026 03:53 PM
Apollo Hospitals: Management Claims Apollo 24/7 Is Set To Reach Cash Breakeven In Q1 FY27, With Reduced Digital Losses Expected To Increase HealthCo Margin To 6.5–7% By Year-End. - Concall Update
Apollo Hospitals: Co. Says Hospital Business Margins Will Return To Normal - CNBC TV18
21 May 2026 09:47 AM
Apollo Hospitals: Co. Says Hospital Business Margins Will Return To Normal - CNBC TV18
Apollo Hospitals: Expects Kolkata Hospital To Become Profitable Within One Year. - CNBC TV18
21 May 2026 09:48 AM
Apollo Hospitals: Expects Kolkata Hospital To Become Profitable Within One Year. - CNBC TV18
Apollo Hospitals: Will Receive ₹750 Crore Cash From the Merger of Apollo Fertility Business, Funds Will Be Used to Expand Diagnostics and Primary Healthcare Network.
21 May 2026 09:49 AM
Apollo Hospitals: Will Receive ₹750 Crore Cash From the Merger of Apollo Fertility Business, Funds Will Be Used to Expand Diagnostics and Primary Healthcare Network.
Apollo Hospitals: Plans To Add 800 More Beds, Expanding In Gurugram With Strong Growth Pipeline For 2027 Expected To Boost Revenue.
21 May 2026 09:50 AM
Apollo Hospitals: Plans To Add 800 More Beds, Expanding In Gurugram With Strong Growth Pipeline For 2027 Expected To Boost Revenue.
Apollo Hospitals: Co Reports 21% Yearly Revenue Growth Driven By Solid Performance - CNBC TV18
21 May 2026 09:50 AM
Apollo Hospitals: Co Reports 21% Yearly Revenue Growth Driven By Solid Performance - CNBC TV18
Apollo Hospitals: Macquarie maintains an Outperform on Apollo Hospitals with a Target Price of ₹6230, citing a modest Q4 beat across revenue, EBITDA and adjusted PAT with margins above estimates, along with the strategic merger of its Mother & Child and Fertility businesses with Cloudnine valued at ₹15.5 billion.
21 May 2026 08:51 AM
Apollo Hospitals: Macquarie maintains an Outperform on Apollo Hospitals with a Target Price of ₹6230, citing a modest Q4 beat across revenue, EBITDA and adjusted PAT with margins above estimates, along with the strategic merger of its Mother & Child and Fertility businesses with Cloudnine valued at ₹15.5 billion.
Apollo Hospitals: Morgan Stanley maintains an Overweight on Apollo Hospitals with a Target Price of ₹8,833, citing Q4 EBITDA beat driven by operating leverage, strong hospital revenue and margin growth, sharply narrowing digital losses, improving digital unit economics, and planned Apollo HealthCo-Keimed demerger/listing by Q4FY27.
21 May 2026 08:51 AM
Apollo Hospitals: Morgan Stanley maintains an Overweight on Apollo Hospitals with a Target Price of ₹8,833, citing Q4 EBITDA beat driven by operating leverage, strong hospital revenue and margin growth, sharply narrowing digital losses, improving digital unit economics, and planned Apollo HealthCo-Keimed demerger/listing by Q4FY27.
APOLLO HOSPITALS ENTERPRISE: Q4 CONS NET PROFIT 5.3B RUPEES VS 3.9B (YOY) || Q4 REVENUE 66B RUPEES VS 55.9B (YOY)
20 May 2026 05:58 PM
APOLLO HOSPITALS ENTERPRISE: Q4 CONS NET PROFIT 5.3B RUPEES VS 3.9B (YOY) || Q4 REVENUE 66B RUPEES VS 55.9B (YOY)
APOLLO HOSPITALS ENTERPRISE: Q4 EBITDA 10.1B RUPEES VS 7.7B (YOY) || Q4 EBITDA MARGIN 15.31% VS 13.76% (YOY)
20 May 2026 05:58 PM
APOLLO HOSPITALS ENTERPRISE: Q4 EBITDA 10.1B RUPEES VS 7.7B (YOY) || Q4 EBITDA MARGIN 15.31% VS 13.76% (YOY)
APOLLO HOSPITALS ENTERPRISE: FINAL DIVIDEND OF 10 RUPEES PER SHARE
20 May 2026 05:58 PM
APOLLO HOSPITALS ENTERPRISE: FINAL DIVIDEND OF 10 RUPEES PER SHARE
Apollo Hospitals Enterprise: Morgan Stanley on Apollo Hospitals Enterprise maintains Overweight with Target Price ₹8,833 (cut from ₹9,209) citing EBITDA cuts from ramp-up losses in new hospitals, higher Apollo 24/7 operating costs, ~2.5–3% EPS downgrade for FY27-28, while revenue outlook remains intact despite persistent margin pressures.
08 Apr 2026 08:57 AM
Apollo Hospitals Enterprise: Morgan Stanley on Apollo Hospitals Enterprise maintains Overweight with Target Price ₹8,833 (cut from ₹9,209) citing EBITDA cuts from ramp-up losses in new hospitals, higher Apollo 24/7 operating costs, ~2.5–3% EPS downgrade for FY27-28, while revenue outlook remains intact despite persistent margin pressures.
